These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9778625)

  • 21. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions.
    Zhou X; Jordan RC; Li Y; Huang BL; Wong DT
    Cancer Genet Cytogenet; 2005 Aug; 161(1):86-9. PubMed ID: 16080964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.
    Naidoo R; Tarin M; Chetty R
    Am J Gastroenterol; 2000 Nov; 95(11):3266-75. PubMed ID: 11095352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer.
    Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT
    Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer.
    Dong JT; Boyd JC; Frierson HF
    Prostate; 2001 Nov; 49(3):166-71. PubMed ID: 11746261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
    Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
    Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precise microdissection of human prostate cancers reveals genotypic heterogeneity.
    Macintosh CA; Stower M; Reid N; Maitland NJ
    Cancer Res; 1998 Jan; 58(1):23-8. PubMed ID: 9426051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
    Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
    Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent allelic losses on chromosome 13q in human male breast carcinomas.
    Wingren S; van den Heuvel A; Gentile M; Olsen K; Hatschek T; Söderkvist P
    Eur J Cancer; 1997 Dec; 33(14):2393-6. PubMed ID: 9616288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
    von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
    Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas].
    Amosenko FA; Kazubskaia TP; Gromyko OE; Matveeva TI; Korchagina EL; Nasedkina TV; Gar'kavtseva RF; Kalinin VN
    Mol Biol (Mosk); 2009; 43(3):414-21. PubMed ID: 19548527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q].
    Latil A; Baron JC; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R
    Bull Cancer; 1995 Jul; 82(7):589-97. PubMed ID: 7549122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
    Macoska JA; Trybus TM; Benson PD; Sakr WA; Grignon DJ; Wojno KD; Pietruk T; Powell IJ
    Cancer Res; 1995 Nov; 55(22):5390-5. PubMed ID: 7585607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of independent origin of multiple tumors from patients with prostate cancer.
    Cheng L; Song SY; Pretlow TG; Abdul-Karim FW; Kung HJ; Dawson DV; Park WS; Moon YW; Tsai ML; Linehan WM; Emmert-Buck MR; Liotta LA; Zhuang Z
    J Natl Cancer Inst; 1998 Feb; 90(3):233-7. PubMed ID: 9462681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.